EPIGENESIS

Serial Number 78790746
606

Registration Progress

Application Filed
Jan 12, 2006
Under Examination
Dec 12, 2006
Approved for Publication
Aug 30, 2006
Published for Opposition
Sep 19, 2006
Registered

Trademark Image

EPIGENESIS

Basic Information

Serial Number
78790746
Filing Date
January 12, 2006
Published for Opposition
September 19, 2006
Abandonment Date
January 11, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 11, 2010
Classes
005

Rights Holder

Epigenesis Pharmaceuticals, LLC

16
Address
2009 Eastpark Boulevard
Cranbury, NJ 08512

Ownership History

Epigenesis Pharmaceuticals, LLC

Original Applicant
16
Cranbury, NJ

Epigenesis Pharmaceuticals, LLC

Owner at Publication
16
Cranbury, NJ

Legal Representation

Attorney
Albert P. Halluin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Jan 11, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 11, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jun 30, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 30, 2009 EX5G S EXTENSION 5 GRANTED Loading...
Jun 8, 2009 EEXT I TEAS EXTENSION RECEIVED Loading...
Jun 8, 2009 EXT5 S EXTENSION 5 FILED Loading...
Dec 1, 2008 EEXT I TEAS EXTENSION RECEIVED Loading...
Dec 1, 2008 EXT4 S EXTENSION 4 FILED Loading...
Dec 1, 2008 EX4G S EXTENSION 4 GRANTED Loading...
Jun 4, 2008 EEXT I TEAS EXTENSION RECEIVED Loading...
Jun 4, 2008 EXT3 S EXTENSION 3 FILED Loading...
Jun 4, 2008 EX3G S EXTENSION 3 GRANTED Loading...
Dec 3, 2007 EEXT I TEAS EXTENSION RECEIVED Loading...
Dec 3, 2007 EXT2 S EXTENSION 2 FILED Loading...
Dec 3, 2007 EX2G S EXTENSION 2 GRANTED Loading...
Jun 5, 2007 EEXT I TEAS EXTENSION RECEIVED Loading...
Jun 5, 2007 EXT1 S EXTENSION 1 FILED Loading...
Jun 5, 2007 EX1G S EXTENSION 1 GRANTED Loading...
Dec 12, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 19, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 30, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Jul 27, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 21, 2006 ALIE A ASSIGNED TO LIE Loading...
Jul 17, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 13, 2006 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 13, 2006 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 13, 2006 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 29, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 18, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM Loading...

Detailed Classifications

Class 005
medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
EPI GENESIS

Classification

International Classes
005